What is Biofire Technologies?
Biofire Technologies operates at the intersection of aerospace engineering, medical device precision, and firearm safety. By leveraging a multidisciplinary team with backgrounds in satellite development, autonomous systems, and supersonic aviation, the company is engineering biometric-enabled firearms designed to prevent unauthorized access. This approach addresses a critical gap in the home defense market, positioning Biofire as a leader in the emerging smart-gun ecosystem. The company's core value proposition lies in its ability to synthesize complex, high-reliability engineering with the stringent safety requirements of personal defense, effectively modernizing a legacy industry through rigorous R&D and proprietary biometric authentication protocols.
How much funding has Biofire Technologies raised?
Biofire Technologies has raised a total of $31M across 2 funding rounds:
Angel/Seed
$17M
Series A
$14M
Angel/Seed (2022): $17M with participation from Gavin de Becker and Ron Conway
Series A (2022): $14M led by Founders Fund
Key Investors in Biofire Technologies
Founders Fund
A prominent venture capital firm known for backing transformative companies in sectors ranging from aerospace to fintech, with a focus on founder-led, high-impact enterprises.
Gavin de Becker
A specialist in security and threat assessment who provides strategic capital to ventures focused on safety and protective technologies.
Ron Conway
A prolific angel investor and venture philanthropist with a long history of supporting early-stage technology companies that disrupt traditional markets.
What's next for Biofire Technologies?
With the successful closure of its Series A financing, Biofire Technologies is poised to accelerate its manufacturing capabilities and expand its market footprint. The strategic focus will likely shift toward scaling production, navigating complex regulatory landscapes, and refining its biometric sensor suite for mass-market reliability. As the company moves into this growth phase, the emphasis will remain on maintaining the high-fidelity engineering standards that have attracted significant venture backing. Future milestones will center on product commercialization and establishing a robust supply chain capable of supporting the anticipated demand for next-generation, secure home defense solutions.
See full Biofire Technologies company page
